These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29945711)

  • 1. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J
    Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?
    Norman JE; Shennan A; Bennett P; Thornton S; Robson S; Marlow N; Norrie J; Petrou S; Sebire N; Lavender T; Whyte S
    BMC Pregnancy Childbirth; 2012 Aug; 12():79. PubMed ID: 22866909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial.
    Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS;
    PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial.
    Landman AJEMC; de Boer MA; Visser L; Nijman TAJ; Hemels MAC; Naaktgeboren CN; van der Weide MC; Mol BW; van Laar JOEH; Papatsonis DNM; Bekker MN; van Drongelen J; van Pampus MG; Sueters M; van der Ham DP; Sikkema JM; Zwart JJ; Huisjes AJM; van Huizen ME; Kleiverda G; Boon J; Franssen MTM; Hermes W; Visser H; de Groot CJM; Oudijk MA
    PLoS Med; 2022 Feb; 19(2):e1003892. PubMed ID: 35104279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Arabin pessary to prevent preterm birth in women with a twin pregnancy and a short cervix: the STOPPIT 2 RCT.
    Norman JE; Norrie J; MacLennan G; Cooper D; Whyte S; Chowdhry S; Cunningham-Burley S; Neilson AR; Mei XW; Smith JB; Shennan A; Robson SC; Thornton S; Kilby MD; Marlow N; Stock SJ; Bennett PR; Denton J
    Health Technol Assess; 2021 Jul; 25(44):1-66. PubMed ID: 34219633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial.
    van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E;
    BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.
    Norman JE; Mackenzie F; Owen P; Mactier H; Hanretty K; Cooper S; Calder A; Mires G; Danielian P; Sturgiss S; MacLennan G; Tydeman G; Thornton S; Martin B; Thornton JG; Neilson JP; Norrie J
    Lancet; 2009 Jun; 373(9680):2034-40. PubMed ID: 19523680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
    Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
    Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V; Saccone G
    Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.
    Vermeulen GM; Bruinse HW
    Br J Obstet Gynaecol; 1999 Jul; 106(7):652-7. PubMed ID: 10428520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.
    Dodd JM; Crowther CA; McPhee AJ; Flenady V; Robinson JS
    BMC Pregnancy Childbirth; 2009 Feb; 9():6. PubMed ID: 19239712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.